OXFORD IMMUNOTEC

oxford-immunotec-logo

Oxford Immunotec is a medical diagnostics company developing novel new tests for various diseases based on its innovative, patented T cell measurement technology. The company's first product is a TB test that diagnoses latent TB infection ( LTBI ) and TB disease. T-SPOT®.TB is an interferon gamma release assay ( IGRA ) which are designed to replace the century old Mantoux skin test ( TST ).

#SimilarOrganizations #People #Financial #Website #More

OXFORD IMMUNOTEC

Social Links:

Industry:
Biotechnology Health Care Health Diagnostics

Founded:
2002-01-01

Address:
Abingdon, Oxfordshire, United Kingdom

Country:
United Kingdom

Website Url:
http://www.oxfordimmunotec.com

Total Employee:
251+

Status:
Active

Contact:
+44 1235 442780

Total Funding:
204.48 M USD

Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible SPF SSL By Default Google Analytics LetsEncrypt Apple Mobile Web Clips Icon WordPress Content Delivery Network Google Universal Analytics


Similar Organizations

celator-pharmaceuticals-logo

Celator Pharmaceuticals

Celator Pharmaceuticals is a biopharmaceutical company developing therapies to treat cancer, using the drug ratio technology platform.


Current Advisors List

scott-requadt_image

Scott Requadt Member of the Board of Directors @ Oxford Immunotec
Board_member

mark-klausner_image

Mark Klausner Member Board Of Directors @ Oxford Immunotec
Board_member
2018-03-01

Current Employees Featured

not_available_image

Peter Smith
Peter Smith Founder and CEO @ Oxford Immunotec
Founder and CEO

not_available_image

Richard M. Altieri
Richard M. Altieri CFO @ Oxford Immunotec
CFO

Founder


not_available_image

Peter Smith

Stock Details


Company's stock symbol is NASDAQ:OXFD

Acquisitions List

Date Company Article Price
2016-10-12 Immunetics Immunetics acquired by Oxford Immunotec 12 M USD
2016-06-23 IMUGEN, Inc. IMUGEN, Inc. acquired by Oxford Immunotec 22.2 M USD
2014-08-05 Boulder Diagnostics Boulder Diagnostics acquired by Oxford Immunotec 7.9 M USD

Investors List

midcap-financial_image

MidCap Financial

MidCap Financial investment in Post-IPO Debt - Oxford Immunotec

invesco-perpetual_image

Invesco

Invesco investment in Venture Round - Oxford Immunotec

wellington-partners_image

Wellington Partners

Wellington Partners investment in Venture Round - Oxford Immunotec

clarus-ventures_image

Clarus Ventures

Clarus Ventures investment in Venture Round - Oxford Immunotec

draper-esprit_image

Molten Ventures

Molten Ventures investment in Venture Round - Oxford Immunotec

spark-ventures_image

Spark Ventures

Spark Ventures investment in Venture Round - Oxford Immunotec

new-leaf-venture-partners_image

New Leaf Venture Partners

New Leaf Venture Partners investment in Venture Round - Oxford Immunotec

kaiser-permanente-ventures_image

Kaiser Permanente Ventures

Kaiser Permanente Ventures investment in Venture Round - Oxford Immunotec

imperial-innovations_image

Imperial Innovations

Imperial Innovations investment in Venture Round - Oxford Immunotec

spark-ventures_image

Spark Ventures

Spark Ventures investment in Series D - Oxford Immunotec

Official Site Inspections

http://www.oxfordimmunotec.com Semrush global rank: 3.96 M Semrush visits lastest month: 3.14 K

  • Host name: a9e86e136e05007af.awsglobalaccelerator.com
  • IP address: 13.248.178.3
  • Location: Seattle United States
  • Latitude: 47.6348
  • Longitude: -122.3451
  • Metro Code: 819
  • Timezone: America/Los_Angeles
  • Postal: 98109

Loading ...

More informations about "Oxford Immunotec"

Oxford Immunotec International

Brand transition. Oxford Immunotec’s T-SPOT.TB test and other leading products and services are now part of Revvity’s portfolio.See details»

Oxford Immunotec North America | Oxford Immunotec is a …

Oxford Immunotec USA, Inc., located in the United States, offers an FDA approved Tuberculosis test, T-SPOT.TB, for detection of TB infection; More accurate than tb skin testsSee details»

Oxford Immunotec is now Revvity

Oxford Immunotec is now Revvity. Oxford Immunotec's T-SPOT.TB test and other leading products and services are now part of Revvity's portfolio. In May 2023, Revvity launched as a …See details»

Oxford Immunotec - Crunchbase Company Profile & Funding

Contact Email marketing@oxfordimmunotec.com Phone Number +44 1235 442780 Oxford Immunotec is a medical diagnostics company developing novel new tests for various diseases …See details»

Oxford Immunotec Medical Education – Medical Education

We are committed to improving patient care for those with immune-related conditions through tuberculosis education for a wide range of healthcare providers—including medical doctors, …See details»

Oxford Immunotec - LinkedIn

Oxford Immunotec | 11,634 followers on LinkedIn. Oxford Immunotec is now Revvity. | Oxford Immunotec is now Revvity. For more information on our transformation, please visit: update ...See details»

Oxford Immunotec Ltd Company Profile - Overview - GlobalData

Website www.oxfordimmunotec.com Telephone 44 1235 442780. No of Employees 190. Industry Medical Equipment. Revenue (2022) $66.3M Gain access to our ...See details»

Oxford Immunotec Company Profile - Office Locations ... - Craft

Mar 12, 2021 Oxford Immunotec has 5 employees across 22 locations. See insights on Oxford Immunotec including office locations, competitors, revenue, financials, executives, subsidiaries …See details»

Oxford Immunotec Company Profile | Management and …

Oxford Immunotec Profile and History. Established in 2002, Oxford Immunotec is a commercial-stage diagnostics company focused on developing and commercializing proprietary tests for …See details»

About Us | Oxford Immunotec International

About Us. About Oxford Immunotec. Oxford Immunotec’s T-SPOT.TB test and other leading products and services are now part of Revvity’s portfolio.See details»

Oxford Immunotec - Overview, News & Similar companies

Jul 15, 2022 Oxford Immunotec contact info: Phone number: +44 1235442780 Website: www.oxfordimmunotec.com What does Oxford Immunotec do? Established in 2002, Oxford …See details»

Oxford Immunotec Global PLC Company Profile & Introduction

Oxford Immunotec Global PLC, a diagnostics company, focuses on developing and commercializing proprietary tests for immunology and infectious diseases in the United States, …See details»

Oxford Immunotec 2025 Company Profile: Valuation, Investors

Oxford Immunotec General Information Description. Developer of T Cell-based diagnostic test products and services designed to focus on developing and commercializing proprietary tests …See details»

Oxford Immunotec - Oxford Diagnostic Laboratories

Oxford Diagnostic Laboratories is a trading division of Oxford Immunotec Ltd., a Revvity Inc Company. T-SPOT is a simplified ELISPOT technique allowing us to determine the T cell …See details»

Oxford Immunotec North America | TB Medical Diagnostics

About Us. About Oxford Immunotec. Oxford Immunotec’s T-SPOT.TB test and other leading products and services are now part of Revvity’s portfolio.See details»

Oxford Immunotec

Www.oxfordimmunotec.com, or the SEC's website, www.sec.gov. Investors should give careful consideration to these risks and uncertainties. Forward-looking statements contained ...See details»

Office Locations - Oxford Immunotec North America

United States. Oxford Immunotec USA, Inc. 293 Boston Post Road West, Suite 210 Marlborough MA 01752 Toll Free: 1-877-208-7768 DDI: 1-508-481-4648Fax: 1-508-213-8124Google MapSee details»

Oxford Immunotec Japan - Crunchbase Company Profile & Funding

Organization. Oxford Immunotec Japan . Connect to CRM . Save . Summary. People. Technology. Signals & News. About. ... Contact Email contact-jp@oxfordimmunotec.com; …See details»

Oxford Immunotec - Seeking Alpha

Www.oxfordimmunotec.com, or the SEC's website, www.sec.gov. Investors should give careful consideration to these risks and uncertainties. Forward-looking statements contained ...See details»

PerkinElmer to Acquire Oxford Immunotec Global PLC

Jan 7, 2021 PDF Version PerkinElmer to acquire Oxford Immunotec for USD 22.00 per share in cash Transaction expected to be completed in the first half of 2021 Jan. 7, 2021- PerkinElmer, …See details»

linkstock.net © 2022. All rights reserved